Chronic Rhinosinusitis and the Coagulation System.
10.4168/aair.2015.7.5.421
- Author:
Dong Young KIM
1
;
Seong H CHO
;
Tetsuji TAKABAYASHI
;
Robert P SCHLEIMER
Author Information
1. Division of Allergy and Immunology, Department of Medicine, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA. rpschleimer@northwestern.edu
- Publication Type:Review
- Keywords:
Rhinosinusitis;
nasal polyps;
coagulation;
fibrinolysis;
tissue plasminogen activator;
factor XIIIa
- MeSH:
Adult;
Asthma;
Blood Coagulation Factors;
Chronic Disease;
Factor XIIIa;
Fibrin;
Fibrinolysis;
Humans;
Nasal Polyps;
Quality of Life;
Thrombin;
Tissue Plasminogen Activator;
Up-Regulation
- From:Allergy, Asthma & Immunology Research
2015;7(5):421-430
- CountryRepublic of Korea
- Language:English
-
Abstract:
Chronic rhinosinusitis (CRS) is one of the most common chronic diseases in adults and severely affects quality of life in patients. Although various etiologic and pathogenic mechanisms of CRS have been proposed, the causes of CRS remain uncertain. Abnormalities in the coagulation cascade may play an etiologic role in many diseases, such as asthma and other inflammatory conditions. While studies on the relationship between asthma and dysregulated coagulation have been reported, the role of the coagulation system in the pathogenesis of CRS has only been considered following recent reports. Excessive fibrin deposition is seen in nasal polyp (NP) tissue from patients with chronic rhinosinusitis with nasal polyp (CRSwNP) and is associated with activation of thrombin, reduction of tissue plasminogen activator (t-PA) and upregulation of coagulation factor XIII-A (FXIII-A), all events that can contribute to fibrin deposition and crosslinking. These findings were reproduced in a murine model of NP that was recently established. Elucidation of the mechanisms of fibrin deposition may enhance our understanding of tissue remodeling in the pathophysiology of NP and provide new targets for the treatment of CRSwNP.
